Cosmos HealthCOSM -7.07%29 EBIT per Share is $-0.52 as of Mar. 2026. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 107 Medical Distribution companies, Cosmos Health ranks better than 88.79% on this metric.
Cosmos Health's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.04.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.52.
During the past 3 years, the average EBIT per Share Growth Rate was 48.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Cosmos Health's EBIT per Share or its related term are showing as below:
COSM'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -274.3 Med: 14.8 Max: 57.9
Current: 48
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cosmos Health was 57.90% per year. The lowest was -274.30% per year. And the median was 14.80% per year.
COSM's 3-Year EBIT Growth Rate is ranked better than 88.79% of 107
companies
in the Medical Distribution industry
Industry Median: 4.2
vs COSM: 48.00
Cosmos Health's EBIT for the
three
months ended in Mar. 2026 was $-1.99 Mil.
Cosmos Health (NAS:COSM) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Cosmos Health EBIT per Share Related Terms
Cosmos Health EBIT per Share Historical Data
* Premium members only.
The historical data trend for Cosmos Health's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (COSM) has a EBIT per Share of $-0.52 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #12 out of 107 companies in the Medical Distribution industry, placing it in the top 11.2%.
Is Cosmos Health's EBIT per Share too high?
Cosmos Health's current EBIT per Share is $-0.52. Based on the distribution chart, Cosmos Health ranks #12 out of 107 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's EBIT per Share compare to HKPD and VNOV?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #12 out of 107 companies for EBIT per Share. This places Cosmos Health in the top 11% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 4.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 107 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current EBIT per Share is $-0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.17 — trading 52.2% below its estimated fair value. The current EBIT per Share is $-0.52. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Cosmos Health (COSM), the current EBIT per Share is $-0.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.17 is trading 52.2% below its estimated GF Value™ of $0.36.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
EBIT per Share: $-0.52
GF Value™: $0.36 vs. price of $0.17 (52.2% below fair value)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
